Know Cancer

or
forgot password

Intervention to Increase Chemotherapy Tolerance in Elderly Cancer Patients


Phase 1
65 Years
N/A
Open (Enrolling)
Both
Colonic Neoplasms

Thank you

Trial Information

Intervention to Increase Chemotherapy Tolerance in Elderly Cancer Patients


Inclusion Criteria:



- Age 65 or older

- Verbal fluency in English

- Diagnosis of colon cancer

- Scheduled to initiate chemotherapy treatment for colon cancer

Exclusion Criteria:

- Active, unstable, untreated serious mental illness interfering with ability to
participate

- Cognitive impairment interfering with ability to participate

- Receiving radiotherapy concomitant with chemotherapy

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Outcome Measure:

Participant satisfaction with intervention structure, timing and content

Outcome Description:

Participants rate acceptability of structure, timing and content of intervention using Likert-type response scales, and are also invited to provide brief qualitative feedback on opinions about intervention.

Outcome Time Frame:

At approximately 12 weeks post-baseline

Safety Issue:

No

Principal Investigator

Lara Traeger, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Massachusetts General Hospital

Authority:

United States: Federal Government

Study ID:

1R03CA157200-01A1

NCT ID:

NCT01586416

Start Date:

December 2012

Completion Date:

May 2013

Related Keywords:

  • Colonic Neoplasms
  • Colonic neoplasms
  • Older adults
  • Psychosocial Intervention
  • Chemotherapy adherence
  • Neoplasms
  • Colonic Neoplasms

Name

Location
Massachusetts General Hospital Boston, Massachusetts  02114-2617